Episode 114: Intravesicular Chemotherapy Considerations for Oncology Nurses
Jul 31, 2020•24 min•Season 1Ep. 114
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
ONS member Clara Beaver, MSN, RN, AOCNS®, ACNS-BC, clinical nurse specialist at Karmanos Cancer Institute in Detroit, MI, member of the ONS Metro Detroit Chapter, and secretary/treasurer for the Oncology Nursing Certification Corporation (ONCC) Board of Directors, joins Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, to discuss intravesicular chemotherapy, how it differs from other chemotherapy treatments, and safe handling recommendations that oncology nurses should be aware of.
Music Credit: "Fireflies and Stardust" by Kevin MacLeod
Licensed under Creative Commons by Attribution 3.0
Episode Notes
Check out these resources from today's episode:
- The NCPD activity for this episode has expired, but you can still earn NCPD through many other Oncology Nursing Podcast episodes. Find a full list of opportunities.
- ONS Communities discussion on intravesicular chemotherapy
- Clinical Journal of Oncology Nursing article: Minimizing Staff Exposure to Antineoplastic Agents During Intravesical Therapy
- ONS book: Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice
- ONS/ONCC Chemotherapy Immunotherapy Certificate Course
- ONS/ONCC Chemotherapy Immunotherapy Certificate Renewal Course
- ONS Fundamentals of Chemotherapy Immunotherapy Administration Course
- ONS Voice article: How Oncology Nurses Support Non-Oncology Units Administering Chemotherapy
- ONS Voice article: What Are ONS's Recommendations for Safe Handling of Hazardous Drugs?
For the best experience, listen in Metacast app for iOS or Android